Appointment of independent non-executive directors and continued suspension of trading
Filed with HKEX · Stock code 2592 · · 4 pages · English
On 6ix: 6ix.com/news/appointment-of-independent-non-executive-directors-and-continued-suspension-of-trading
Cloudbreak Pharma, Inc. on 6ix
Earlier from Cloudbreak Pharma
- Business updates and supplemental announcement in relation to 2025 annual report
- Suspension of trading
- Cloudbreak Pharma Announces Results of First-of-Its-Kind Patient Survey on Pinguecula, Confirming Significant Unmet Need and Impact on Quality of Life
- Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
- Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum
Later from Cloudbreak Pharma
- List of directors and their roles and functions
- Formation of an independent Special committee; delay in publication and despatch of 2026 interim report; and continued suspension of trading
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow Cloudbreak Pharma into a list and get an email when it puts out news.
Follow Cloudbreak Pharma